EpiPen: 1st generic version receives FDA approval
by Press Release from Outbreak News Today on (#3WZ4N)
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds. Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in ["]
The post EpiPen: 1st generic version receives FDA approval appeared first on Outbreak News Today.